These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2441676)

  • 21. Kininogens are antithrombotic proteins In vivo.
    Colman RW; White JV; Scovell S; Stadnicki A; Sartor RB
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2245-50. PubMed ID: 10479669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of kininogens in human malignant ascites.
    Karlsrud TS; Buø L; Aasen AO; Johansen HT
    Thromb Res; 1991 Sep; 63(6):641-50. PubMed ID: 1780808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of carbohydrate in rat plasma thiostatin: deglycosylation destroys cysteine proteinase inhibition activity.
    Rusiniak ME; Bedi GS; Back N
    Biochem Biophys Res Commun; 1991 Sep; 179(2):927-32. PubMed ID: 1654903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen.
    Olafsson I; Löfberg H; Abrahamson M; Grubb A
    Scand J Clin Lab Invest; 1988 Oct; 48(6):573-82. PubMed ID: 3064278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation.
    Acuña-Castillo C; Aravena M; Leiva-Salcedo E; Pérez V; Gómez C; Sabaj V; Nishimura S; Pérez C; Colombo A; Walter R; Sierra F
    Mech Ageing Dev; 2005 Dec; 126(12):1284-91. PubMed ID: 16140359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum.
    Lonsdale-Eccles JD; Mpimbaza GW; Nkhungulu ZR; Olobo J; Smith L; Tosomba OM; Grab DJ
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):549-56. PubMed ID: 7832773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both T- and K-kininogens increase in the serum of old rats but by different mechanisms.
    Sierra F
    Mech Ageing Dev; 1995 Oct; 84(2):127-37. PubMed ID: 8788240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination between rat thiostatin (T-kininogen) and one of its cystatin-like inhibitory fragments by a monoclonal antibody, and localization of the epitope.
    Lalmanach G; Adam A; Moreau T; Gutman N; Gauthier F
    Eur J Biochem; 1991 Feb; 196(1):73-8. PubMed ID: 1705888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine-proteinase-inhibiting function of T kininogen and of its proteolytic fragments.
    Moreau T; Esnard F; Gutman N; Degand P; Gauthier F
    Eur J Biochem; 1988 Apr; 173(1):185-90. PubMed ID: 3356189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin L, but not cathepsin B, is a potential kininogenase.
    Desmazes C; Gauthier F; Lalmanach G
    Biol Chem; 2001 May; 382(5):811-5. PubMed ID: 11517935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of several isoforms of T-kininogen expressed in the liver of aging rats.
    Sierra F; Walter R; Vautravers P; Guigoz Y
    Arch Biochem Biophys; 1995 Oct; 322(2):333-8. PubMed ID: 7574705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication.
    Kellermann J; Lottspeich F; Henschen A; Müller-Esterl W
    Eur J Biochem; 1986 Jan; 154(2):471-8. PubMed ID: 3484703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of nephrectomy and surgery on plasma kininogens and angiotensinogen in the rat.
    Suzuki H; Alhenc-Gelas F; Bouhnik J; Corvol P; Ménard J
    Endocrinology; 1988 Jun; 122(6):2809-15. PubMed ID: 3371263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enkephalin analogs as substrates for the assay of brain cysteine proteinase (Cathepsin L) and its endogenous inhibitors.
    Marks N; Berg MJ; Danho W
    Peptides; 1989; 10(2):391-4. PubMed ID: 2787909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute-phase reactant proteins and antioxidants in rats intoxicated chronically with paraquat.
    Minakata K; Suzuki O; Oh-ishi S; Hayashi I; Saito S; Harada N
    J Toxicol Environ Health; 1995 Jan; 44(1):29-41. PubMed ID: 7529839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human liver cathepsin L by alpha-thiol proteinase inhibitor.
    Pagano M; Engler R
    FEBS Lett; 1982 Feb; 138(2):307-10. PubMed ID: 7067841
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
    Walsh PN; Sinha D; Kueppers F; Seaman FS; Blankstein KB
    J Clin Invest; 1987 Dec; 80(6):1578-86. PubMed ID: 3500185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a microassay for human kininogens as cysteine protease inhibitors.
    Karlsrud TS; Aasen AO; Johansen HT
    J Pharmacol Methods; 1991 Sep; 26(2):113-24. PubMed ID: 1943122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of rat T-kininogen using immunological methods. Application to inflammatory processes.
    Adam A; Damas J; Calay G; Renard C; Remacle-Volon G; Bourdon V
    Biochem Pharmacol; 1989 May; 38(10):1569-75. PubMed ID: 2730673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.